During the past decade, CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc" are "Diabetes Mellitus" (3 trials), "Gastroparesis" (3 trials), "Heart Failure" (2 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Kidney Disease, Chronic" (1 trials). Many other conditions were trialed in "CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc" in a lesser frequency.

Most popular intervention types in "CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (3 trials), "Relamorelin" (3 trials), "Tirzepatide" (2 trials) and "BI 690517" (1 trials). Other intervention names were less common.

The vast majority of trials in "CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc" are 10 trials for "All" genders.

Currently, there are NaN active trials in "CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc has several departments that took part in Clinical trials: "Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares" - 3 trials